UNSPSC 51401523: Etizolam

This classification denotes a benzodiazepine with the molecular formula C17H15ClN4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A76XI0HL37, chemically known as 8-ethyl-6-(o-chlorophenyl)-1-methyl-4h-s-triazolo(3,4c)thieno(2,3e)-1,4-diazepine but generally known as etizolam, which bears US NIH Compound Identifier 3307. European Medicines Agency schedules Etizolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07313MIG.

UNSPSC 51401523 Etizolam is a Commodity code that state and local procurement offices use to classify controlled and pharmaceutical substances for public health and emergency response applications. Based on recent solicitation activity, the code captures purchases of pharmaceutical interventions including naloxone and related drug-response products for community health and harm-reduction initiatives. Issuing bodies soliciting under this code include county health departments and public health authorities managing substance-use response programs.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline. The procurement mandates quarterly deliveries to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping costs. Bidders must provide unit costs, meet drug-free workplace and E-Verify compliance requirements, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period allowing termination at will. FEMA funding involvement introduces additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act, with potential audit and record-inspection authority.